Biohaven (BHVN) Current Assets (2021 - 2026)
Biohaven (BHVN) posted Current Assets of $385.6 million for Q1 2026, up 4.7% sequentially from $368.3 million in Q4 2025, and up 0.76% YoY from $382.8 million in Q1 2025.
Biohaven (BHVN) Current Assets (2021 - 2026) Analysis & Trends
Biohaven has reported Current Assets for 6 years, with the latest figure at $385.6 million in Q1 2026.
- Quarterly Current Assets rose 0.76% year-over-year to $385.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $385.6 million (up 0.76% YoY) and the FY2025 annual result came in at $368.3 million, down 31.6% from the prior year.
- Current Assets grew to $385.6 million in Q1 2026 per BHVN's latest filing, from $368.3 million in the prior quarter.
- Over five years, Current Assets peaked at $587.0 million in Q4 2022 and troughed at $80.6 million in Q3 2022.
- A 5-year average of $411.6 million and a median of $434.1 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2024: Current Assets surged 519.01% in 2022, then slumped 35.95% in 2024.
- Over 5 years, Current Assets stood at $587.0 million in 2022, then declined by 24.62% to $442.4 million in 2023, then grew by 21.7% to $538.5 million in 2024, then plunged by 31.6% to $368.3 million in 2025, then grew by 4.7% to $385.6 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $385.6 million, $368.3 million, and $323.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | 296.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 296.56 Mn |
| Mar 31, 2026 | 385.65 Mn |
| Dec 31, 2025 | 368.33 Mn |
| Sep 30, 2025 | 323.62 Mn |
| Jun 30, 2025 | 474.83 Mn |
| Mar 31, 2025 | 382.76 Mn |
| Dec 31, 2024 | 538.47 Mn |
| Sep 30, 2024 | 440.50 Mn |
| Jun 30, 2024 | 511.27 Mn |
| Mar 31, 2024 | 348.74 Mn |
| Dec 31, 2023 | 442.45 Mn |
| Sep 30, 2023 | 310.57 Mn |
| Jun 30, 2023 | 434.12 Mn |
| Mar 31, 2023 | 544.48 Mn |
| Dec 31, 2022 | 586.97 Mn |
| Sep 30, 2022 | 80.55 Mn |
| Dec 31, 2021 | 94.82 Mn |